Sanofi Allegra Switch Approval Triggers Race To Market For Perrigo
This article was originally published in The Tan Sheet
Executive Summary
Sanofi-Aventis will launch nonprescription Allegra allergy relief products March 4, but the line might not beat private-label fexofenadine products to store shelves.
You may also be interested in...
Advertising Review In Brief
Chattem supports Allegra’s “fast” claims
More Consumers Turn To Pharmacists For OTC Advice – Study
Tight economic conditions are driving more consumers to pharmacists for advice on self-care with OTC remedies, an American Pharmacists Association study finds.
Perrigo Takes Two Steps Forward: Generic Allegra Launch, Manufacturing Compliance
Perrigo stokes momentum behind already healthy sales growth with significant steps in separate areas: a green light for regulatory compliance at its main manufacturing plant, and the launch of its generic OTC versions of Sanofi-Aventis' Allegra.